{"id":95840,"date":"2015-03-31T09:37:55","date_gmt":"2015-03-31T07:37:55","guid":{"rendered":"https:\/\/clinical.r-biopharm.com\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/"},"modified":"2019-08-07T14:56:55","modified_gmt":"2019-08-07T12:56:55","slug":"il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab","status":"publish","type":"post","link":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/","title":{"rendered":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab"},"content":{"rendered":"<div class=\"wpb-content-wrapper\">[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1565182560470{margin-bottom: 0px !important;}&#8221;]<strong>Lo studio sul primo test di controllo randomizzato ha dimostrano che le decisioni\u00a0sui\u00a0trattamenti clinici basate sul monitoraggio terapeutico dei farmaci (TDM) \u00e8 superiore alla strategia di intensificazione della dose.<\/strong><!--more--><\/p>\n<p>Un\u00a0metodo comune di trattamento dei pazienti\u00a0con mancanza di risposta alla terapia con\u00a0infliximab (IFX) \u00e8 quello di intensificarne il dosaggio. Steenholdt et al.\u00a0 hanno mostrato nel loro studio, che gli interventi basati sul monitoraggio terapeutico\u00a0consentono di raggiungere\u00a0risultati di qualit\u00e0 clinica, biologica e di vita simili\u00a0a quelli ottenuti con l\u2019intensificazione di dose ma a costi significativamente inferiori.<\/p>\n<p>Il risultato principale dello studio in breve:[\/vc_column_text][mk_custom_list style=&#8221;mk-moon-circle-small&#8221;]\n<ul>\n<li>I risultati singoli della terapia con infliximab mostrano una percentuale di risposta clinica simile alla strategia di intensificazione del dosaggio corrente.<\/li>\n<li>I costi del trattamento sono sostanzialmente ridotti nei pazienti in terapia di monitoraggio della dose con infliximab<\/li>\n<li>I meccanismi farmacodinamici di fallimento della terapia sono pi\u00f9 comuni\u00a0rispetto alla\u00a0immunogenicit\u00e0 del farmaco.<\/li>\n<\/ul>\n[\/mk_custom_list][vc_column_text css=&#8221;.vc_custom_1565182552346{margin-bottom: 0px !important;}&#8221;]Vuoi ricevere maggiori dettagli? Leggi l&#8217;<a title=\"Abstract\" href=\"http:\/\/gut.bmj.com\/content\/63\/6\/919.short\">abstract<\/a>.<\/p>\n<p>* Steenholdt C, et al. Gut 2014;63:919-927.[\/vc_column_text][vc_cta h2=&#8221;Hai domande?&#8221; shape=&#8221;square&#8221; style=&#8221;flat&#8221; add_button=&#8221;right&#8221; btn_title=&#8221;Contattaci&#8221; btn_style=&#8221;flat&#8221; btn_shape=&#8221;square&#8221; btn_color=&#8221;inverse&#8221; btn_link=&#8221;url:mailto%3Aifx%40r-biopharm.de|&#8221;]Come eseguire il monitoraggio terapeutico di Infliximab e dei suoi Biosimilari? Consulta la <a href=\"https:\/\/clinical.r-biopharm.com\/products\/ridascreen-ifx-monitoring\/\">pagina web<\/a> dedicata a RIDASCREEN IFX Monitoring oppure scarica la brochure. Vuoi ricevere maggiori informazioni? Contatta R-Biopharm Italia.[\/vc_cta][\/vc_column][\/vc_row]\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_column_text css=&#8221;.vc_custom_1565182560470{margin-bottom: 0px !important;}&#8221;]Lo studio sul primo test di controllo randomizzato ha dimostrano che le decisioni\u00a0sui\u00a0trattamenti clinici basate sul monitoraggio terapeutico dei farmaci (TDM) \u00e8 superiore alla strategia di intensificazione della dose.<\/p>\n","protected":false},"author":27,"featured_media":95843,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[476,478,479],"tags":[],"class_list":["post-95840","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-elisa-it","category-gastroenterologia","category-monitoraggio-terapeutico-dei-farmaci"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics<\/title>\n<meta name=\"description\" content=\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Diagnostics\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-31T07:37:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-08-07T12:56:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"690\" \/>\n\t<meta property=\"og:image:height\" content=\"252\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Janine Dege\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Janine Dege\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\"},\"author\":{\"name\":\"Janine Dege\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"headline\":\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab\",\"datePublished\":\"2015-03-31T07:37:55+00:00\",\"dateModified\":\"2019-08-07T12:56:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg\",\"articleSection\":[\"ELISA\",\"Gastroenterologia\",\"Monitoraggio terapeutico dei farmaci\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\",\"url\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\",\"name\":\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg\",\"datePublished\":\"2015-03-31T07:37:55+00:00\",\"dateModified\":\"2019-08-07T12:56:55+00:00\",\"author\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\"},\"description\":\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab\",\"breadcrumb\":{\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage\",\"url\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg\",\"contentUrl\":\"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg\",\"width\":690,\"height\":252},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/clinical.r-biopharm.com\/it\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#website\",\"url\":\"https:\/\/clinical.r-biopharm.com\/fr\/\",\"name\":\"Clinical Diagnostics\",\"description\":\"A Division of the R-Biopharm Group\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f\",\"name\":\"Janine Dege\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g\",\"caption\":\"Janine Dege\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics","description":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/","og_locale":"it_IT","og_type":"article","og_title":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics","og_description":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab","og_url":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/","og_site_name":"Clinical Diagnostics","article_published_time":"2015-03-31T07:37:55+00:00","article_modified_time":"2019-08-07T12:56:55+00:00","og_image":[{"width":690,"height":252,"url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg","type":"image\/jpeg"}],"author":"Janine Dege","twitter_misc":{"Written by":"Janine Dege","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#article","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/"},"author":{"name":"Janine Dege","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"headline":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab","datePublished":"2015-03-31T07:37:55+00:00","dateModified":"2019-08-07T12:56:55+00:00","mainEntityOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/"},"wordCount":278,"image":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg","articleSection":["ELISA","Gastroenterologia","Monitoraggio terapeutico dei farmaci"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/","url":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/","name":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab - Clinical Diagnostics","isPartOf":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage"},"image":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage"},"thumbnailUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg","datePublished":"2015-03-31T07:37:55+00:00","dateModified":"2019-08-07T12:56:55+00:00","author":{"@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f"},"description":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab","breadcrumb":{"@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#primaryimage","url":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg","contentUrl":"https:\/\/clinical.r-biopharm.com\/wp-content\/uploads\/2015\/03\/IFX-Drug-Monitoring-reduces-treatment-costs-1.jpg","width":690,"height":252},{"@type":"BreadcrumbList","@id":"https:\/\/clinical.r-biopharm.com\/it\/news\/il-monitoraggio-farmacologico-riduce-i-costi-del-trattamento-con-infliximab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinical.r-biopharm.com\/it\/home\/"},{"@type":"ListItem","position":2,"name":"Il monitoraggio farmacologico riduce i costi del trattamento con Infliximab"}]},{"@type":"WebSite","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#website","url":"https:\/\/clinical.r-biopharm.com\/fr\/","name":"Clinical Diagnostics","description":"A Division of the R-Biopharm Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinical.r-biopharm.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/7bcf9ead36ba80c48ad551e786874e6f","name":"Janine Dege","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/clinical.r-biopharm.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4cbca03fc07097934a5058c95fc3b1baaf182a156a174233532f9c3887c50eee?s=96&d=mm&r=g","caption":"Janine Dege"}}]}},"_links":{"self":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/95840","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/comments?post=95840"}],"version-history":[{"count":3,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/95840\/revisions"}],"predecessor-version":[{"id":98759,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/posts\/95840\/revisions\/98759"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/media\/95843"}],"wp:attachment":[{"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/media?parent=95840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/categories?post=95840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinical.r-biopharm.com\/it\/wp-json\/wp\/v2\/tags?post=95840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}